Seven Eight Capital, LP Biomarin Pharmaceutical Inc Transaction History

Seven Eight Capital, LP

  • $1.05 Billion
  • Q3 2024

A detailed history of Seven Eight Capital, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Seven Eight Capital, LP holds 19,336 shares of BMRN stock, worth $1.23 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
19,336
Holding current value
$1.23 Million
% of portfolio
0.13%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$69.02 - $93.84 $1.33 Million - $1.81 Million
19,336 New
19,336 $1.36 Million
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $6.56 Million - $7.29 Million
-77,146 Reduced 96.68%
2,653 $234,000
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $2.37 Million - $2.74 Million
27,310 Added 52.03%
79,799 $6.92 Million
Q1 2023

May 12, 2023
BUY
$87.74 - $117.27 $4.3 Million - $5.75 Million
49,051 Added 1426.73%
52,489 $5.1 Million
Q4 2022

Feb 13, 2023
BUY
$80.93 - $108.63 $278,237 - $373,469
3,438 New
3,438 $355,000
Q2 2022

Aug 04, 2022
SELL
$71.48 - $86.85 $3.88 Million - $4.72 Million
-54,340 Reduced 95.45%
2,588 $214,000
Q1 2022

May 11, 2022
BUY
$74.28 - $92.69 $3.67 Million - $4.59 Million
49,474 Added 663.72%
56,928 $4.39 Million
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $2.62 Million - $3.34 Million
-36,506 Reduced 83.04%
7,454 $659,000
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $2.58 Million - $2.95 Million
34,500 Added 364.69%
43,960 $3.4 Million
Q2 2021

Aug 13, 2021
BUY
$75.51 - $84.79 $714,324 - $802,113
9,460 New
9,460 $789,000
Q1 2020

May 14, 2020
SELL
$71.37 - $96.85 $1.49 Million - $2.02 Million
-20,818 Closed
0 $0
Q4 2019

Feb 13, 2020
SELL
$64.27 - $86.37 $978,703 - $1.32 Million
-15,228 Reduced 42.25%
20,818 $1.76 Million
Q3 2019

Nov 14, 2019
BUY
$67.4 - $85.11 $2.43 Million - $3.07 Million
36,046 New
36,046 $2.43 Million
Q2 2019

Aug 12, 2019
SELL
$80.35 - $93.9 $721,301 - $842,940
-8,977 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$84.2 - $98.62 $755,863 - $885,311
8,977 New
8,977 $797,000
Q4 2018

Feb 14, 2019
SELL
$80.14 - $106.07 $1.44 Million - $1.91 Million
-17,977 Closed
0 $0
Q3 2018

Oct 18, 2018
BUY
$93.92 - $105.72 $535,344 - $602,604
5,700 Added 46.43%
17,977 $1.74 Million
Q2 2018

Aug 07, 2018
BUY
$76.01 - $99.03 $933,174 - $1.22 Million
12,277 New
12,277 $1.16 Million
Q4 2017

Feb 12, 2018
SELL
$80.76 - $95.13 $226,128 - $266,364
-2,800 Closed
0 $0
Q3 2017

Oct 16, 2017
SELL
$80.6 - $94.95 $2.64 Million - $3.11 Million
-32,800 Reduced 92.13%
2,800 $261,000
Q2 2017

Aug 10, 2017
BUY
N/A
35,600
35,600 $3.23 Million

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email